Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Sakurai, Takashi ^b   Akiyama, Hiroyuki ^b   Oka, Toru ^b   Sekita, Kenn Ichi ^b   Yokono, Koichi ^b   Goto, Takeo ^a  

^a Takasago Municipal Hospital   (Japan)

^b NONE

Author keywords

APO E allele; Apolipoprotein; LCAT; Lipid abnormalities; Long term hemodialysis

Indexed keywords

ADULT; AGED; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; UREMIA; ARTICLE; BLOOD; DIABETES MELLITUS; GENETICS; MIDDLE AGED; PHENOTYPE; RENAL REPLACEMENT THERAPY; TIME;

APOLIPOPROTEIN; APOLIPOPROTEIN E; LIPID;

AGED; APOLIPOPROTEINS; APOLIPOPROTEINS E; DIABETES COMPLICATIONS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; RENAL DIALYSIS; TIME FACTORS; UREMIA;

EID: 0033007720     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. SAKURAI T, OKA T, HASEGAWA H, IGAKI N, MIKI S, GOTO T: Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease. Nephron 61:409-414, 1992
2. KIKKAWA R, ARIMURA T, HAEDA M, NISHIO T, SAWADA K, YAGISAWA M, SHIGETA Y: Current status of type 2 (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 36:1105-1108, 1993
3. ATTMAN PO, SAMUELSSON O, ALAUPOVIC P: Lipoprotein metabolism and renal failure. Am J Kidney Dis 21:573-592, 1993
4. WANNER C, FROMMHERZ K, HÖRL WH: Hyperlipoproteinemia in chronic renal failure: Pathophysiological and therapeutic aspects. Cardiology 78:202-217, 1991
5. REAVEN GM: Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Am J Med 83(Suppl 3A):31-40, 1987
6. UUSTITUPA MIJ, NISKANEN LK, SIITONEN OM, VOUTILAINEN E, PYÖRÄLÄ K: 5-Year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-diabetic and nondiabetic subjects. Circulation 82:27-36, 1990
7. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
8. MENZEL HJ, UTERMANN G: Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis 7:492-495, 1986
9. YOSHIZAWA T, YAMAKAWA-KOBAYASHI K, KOMATSUZAKI Y, ARINAMI T, OGUNI E, MIZUSAWA H, SHOJI S, HAMAGUCHI H: Dose-dependent association of apolipoprotein E4 allele ε4 with lateonset, sporadic Alzheimer's disease. Ann Neurol 36:656-659, 1994
10. MAHLEY RW: Apoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988.